Stryker (SYK) Tops Q3 EPS by 2c, Offers Outlook

Stryker (NYSE: SYK) reported Q3 EPS of $1.25, $0.02 better than the analyst estimate of $1.23. Revenue for the quarter came in at $2.4 billion versus the consensus estimate of $2.44 billion.

Stryker sees FY2015 EPS of $5.07-$5.12, versus the consensus of $5.11.

"We expect 2015 constant currency sales growth in the range of 6.5% to 7.5%, including organic sales growth in the range of 5.5% to 6.5%. Based on current foreign currency exchange rates, we expect adjusted diluted net earnings per share to be in the range of $5.07-$5.12 for the full year. If foreign currency exchange rates hold near current levels, we expect sales in the full year of 2015 to be negatively impacted by approximately 4.0% and adjusted diluted net earnings per share to be negatively impacted by approximately $0.25 in the full year."

For earnings history and earnings-related data on Stryker (SYK) click here.

You May Also Be Interested In

• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
• Stryker completes first surgery using FDA-cleared Apple Vision Pro app
• National Health Investors (NHI) PT Lowered to $80 at Truist Securities